2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1935
Submitter : Dr. Susan Dudley Date & Time: 10/31/2005 04:10:39
Organization : Dr. Susan Dudley
Category : Individual Consumer
Issue Areas/Comments
1
A. Should FDA initiate a rulemaking to codify its interpretation of section 503(b) of the action regarding when an active ingredient can be simultaneously marketed in both prescription drug product and an OTC drug product?
NO
1.
A. Should FDA initiate a rulemaking to codify its interpretation of section 503(b) of the act regarding when an active ingredient can be simultaneously market in both a prescription drug product and an OTC drug product?
NO
B. Is there significant confusion regarding FDA's interpretation of section 503(b) of the act?
NO
C. If so, would a rulemaking on this issue help dispet that confusion?
Rulemaking is not needed.
2
A. If FDA limited sale of an OTC product to a particular subpopulation, e.g., by making the product available to the subpopulation by prescription only, would FDA be able to enforce such a limitation as a matter of law?
Cigarettes, alcohol, nicotine patches are legally available only to people over set ages. Pharmacy sales regulation is NOT the function of the FDA.
B. If it could, would it be able to do so as practical matter and, if so, how?
Pharmacy sales regulation is NOT the function of the FDA.
3
A. Assuming it is legal to market the same active ingredient in both a prescription and OTC product, may the different products be legally sold in the same package?
YES
B. If the two products may be lawfully sold in a single package, under what circumstances would it be inappropriate to do so?
NONE
GENERAL
GENERAL
There is no excuse for this delay in granting OTC status to PLAN B. SCIENCE, not ideology must dictate the actions of the FDA or the AGENCY BECOMES A SHAM and NO DECISIONS IT MAKES WILL BE TRUSTWORTHY.